1. Academic Validation
  2. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

  • J Med Chem. 2000 Sep 21;43(19):3482-6. doi: 10.1021/jm0002679.
Y S Babu 1 P Chand S Bantia P Kotian A Dehghani Y El-Kattan T H Lin T L Hutchison A J Elliott C D Parker S L Ananth L L Horn G W Laver J A Montgomery
Affiliations

Affiliation

  • 1 BioCryst Pharmaceuticals, Inc., 2190 Parkway Lake Drive, Birmingham, Alabama 35244, USA. babu@biocryst.com
Figures
Products